Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haematopoietic graft engineering.

W Y K Hwang1

  • 1Department of Haematology, Singapore General Hospital, Singapore.

Annals of the Academy of Medicine, Singapore
|November 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.

Annals of hematology·2017
Same author

Recurrent trichosporonosis with central nervous system involvement in an allogeneic hematopoietic stem cell transplant recipient.

Transplant infectious disease : an official journal of the Transplantation Society·2016
Same author

Inadvertent completely HLA-mismatched allogeneic unrelated bone marrow transplant: lessons learned.

Bone marrow transplantation·2016
Same author

Early relapse post autologous transplant is a stronger predictor of survival compared with pretreatment patient factors in the novel agent era: analysis of the Singapore Multiple Myeloma Working Group.

Bone marrow transplantation·2016
Same author

Novel HLA class I and II alleles identified during routine registry typing in 2010.

Tissue antigens·2011
Same author

Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same journal

"Gazing into the crystal ball of mortality prediction in conservative kidney care": Correspondence.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Vascular stiffness and sepsis mortality: A promising signal in search of clinical relevance.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Transcatheter aortic valve implantation for severe aortic regurgitation with Trilogy system: Initial Southeast Asia experience.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Singapore expert consensus on optimising lipid-lowering strategies in acute coronary syndrome: A modified Delphi study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Association of estimated pulse wave velocity with 28-day mortality in sepsis: A MIMIC-IV study.

Annals of the Academy of Medicine, Singapore·2026
Same journal

Prognostic value of the monocyte-to-albumin ratio in nasopharyngeal carcinoma: A retrospective cohort study.

Annals of the Academy of Medicine, Singapore·2026
See all related articles

Hematopoietic stem cell transplantation (HSCT) can be improved by engineering the graft. Graft engineering techniques enhance effectiveness against cancers and immune diseases, with future potential for wider patient benefit.

Area of Science:

  • Hematology
  • Immunology
  • Cancer Therapy

Background:

  • Hematopoietic stem cell transplantation (HSCT) is a vital treatment but has limitations in treating hematologic and immune diseases.
  • Graft manipulation techniques are being developed to enhance HSCT efficacy.

Purpose of the Study:

  • To review methods for engineering the hematopoietic stem cell (HSC) graft.
  • To discuss regulatory considerations in hematopoietic graft engineering.

Main Methods:

  • Review of current techniques for HSC graft manipulation.
  • Discussion of graft engineering strategies including cell removal, expansion, and addition.

Main Results:

  • Graft engineering involves removing detrimental cells (e.g., those causing graft-versus-host disease or relapse).

Related Experiment Videos

  • Techniques also include expanding donor cells for adequate dosage and adding selected cells to improve function.

    • Conclusions:

    • Hematopoietic graft engineering is advancing beyond its early stages.
    • Further developments are expected to broaden the application of these techniques to benefit more patients in the coming decade.